Collegium Pharmaceutical Inc. share price logo

Collegium Pharmaceutical Inc.

NASDAQ: COLL

Small Cap

$28.23

+0.08

(+0.28%)

as on

Collegium Pharmaceutical Inc. Stock Performance

as on August 15, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $27.14
    $28.52
    downward going graph

    3.86%

    Downside

    1.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $25.47
    $50.79
    downward going graph

    9.78%

    Downside

    79.90%

    Upside

    downward going graph

Collegium Pharmaceutical Inc. share price movements today

Previous Close
$28.15
Open
$27.52
Volume
578.1K
Day's Low - High
$27.14 - $28.52
52 Week Low - High
$25.47 - $50.79

Collegium Pharmaceutical Inc. Historical Returns

1 Month Return
-19.62 %
3 Month Return
-19.18 %
1 Year Return
-24.25 %
3 Year Return
+ 20.15 %
5 Year Return
+ 58.59 %

Collegium Pharmaceutical Inc. Stock Fundamentals & Key Indicators

Check Collegium Pharmaceutical Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$833.5M

EPS (TTM)

7.5323

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.47%

PE Ratio (TTM)

20.4

Industry PE ratio

5.024782608695652

PEG Ratio

0

EBITDA

405.3M

Revenue (TTM)

808.2M

Profit Margin

5.93%

Return On Equity TTM

17.61%

Collegium Pharmaceutical Inc. Stock Valuation

Track how Collegium Pharmaceutical Inc. P/E has moved over time to understand its valuation trends.

Collegium Pharmaceutical Inc. in the last 5 years

  • Overview

  • Trends

Lowest (4.50x)

June 30, 2025

Industry (5.02x)

August 14, 2026

Today (20.40x)

August 14, 2026

Highest (9.56x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 20.40x

Collegium Pharmaceutical Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Collegium Pharmaceutical Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$833.5M58.59%20.45.93%NA
BUY$21.5B147.39%17.9741.56%NA
HOLD$18.5B7.29%NA-2.79%2.9499999999999997%
BUY$43.2BNA2014.55%2.02%
BUY$30.4B-62.36%12.2827.69%2.73%

Stock Returns calculator for Collegium Pharmaceutical Inc. Stock including INR - Dollar returns

The Collegium Pharmaceutical Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Collegium Pharmaceutical Inc. investment value today

Current value as on today

₹82,841

Returns

-₹17,159

(-17.16%)

Returns from Collegium Pharmaceutical Inc. Stock

-₹24,031 (-24.03%)

Dollar Impact

₹6,873 (+6.87%)

Analyst Recommendation on Collegium Pharmaceutical Inc. Stock

Based on 12 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 12 analysts, 75% of analysts recommend a 'BUY' rating for Collegium Pharmaceutical Inc.. Average target price of $51.2

Collegium Pharmaceutical Inc. Share Price Target

Get share price movements and forecasts by analysts on Collegium Pharmaceutical Inc..

What analysts predicted

44.86%UPSIDE

Target Price

$51.2

Current Price

$28.23

Analyzed by

12 Analysts

Target

$51.20

Collegium Pharmaceutical Inc. target price $51.2, a slight upside of 44.86% compared to current price of $28.23. According to 12 analysts rating.

Indian Investors' Interest in Collegium Pharmaceutical Inc. Stock

Search interest for Collegium Pharmaceutical Inc. Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:23% versus previous 30 day period

Collegium Pharmaceutical Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
144
145
159
181
177
188
209
205
193
199
Gross Profit
91
90
96
98
97
108
129
128
117
110
Operating Income
49
47
34
38
21
35
63
59
31
3
EBITDA
89
80
75
96
80
94
121
303
90
70
Interest Expense
17
15
18
22
20
20
21
104
15
19
Depreciation
35
35
41
56
56
56
56
56
55
64
Income Before Tax
36
29
15
17
3
17
43
29
18
-13
Income Tax Expense
8
9
6
4
0
5
11
12
4
1
Net Income
27
19
9
12
2
11
31
16
14
-15
Net Profit Margin
19.12%
13.50%
5.86%
6.89%
1.36%
6.37%
15.05%
8.26%
7.49%
-7.53%

Collegium Pharmaceutical Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
28
280
296
310
276
463
566
631
780
Gross Profit
1
25
114
103
179
150
209
326
377
463
Operating Income
-94
-75
-20
-23
56
17
33
166
169
187
EBITDA
-93
-74
91
-6
118
86
173
308
341
401
Interest Expense
0
0
20
0
28
21
63
83
73
82
Depreciation
-
0
110
15
61
68
138
149
169
226
Income Before Tax
-94
-74
-39
-22
27
-3
-28
75
98
92
Income Tax Expense
0
-1
-110
-14
0
-74
-3
27
29
29
Net Income
-94
-74
-39
-22
26
71
-25
48
69
62
Net Profit Margin
-5504.15%
-262.91%
-13.95%
-7.66%
8.63%
25.83%
-5.39%
8.50%
10.96%
8.05%

Collegium Pharmaceutical Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
19
9
12
2
11
31
16
14
-15
Operating Cash Flow
67
-8
84
55
72
78
123
57
71
Investing Cash Flow
-8
-248
-11
-9
-2
-30
-20
1
-502
Financing Cash Flow
-114
149
-41
-25
-48
-14
-21
-21
292
Change in Cash
-55
-108
31
20
21
32
81
37
-139

Collegium Pharmaceutical Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-74
-39
-22
26
71
-25
48
69
62
Operating Cash Flow
-67
169
27
93
103
124
274
204
329
Investing Cash Flow
0
-24
-6
-373
-1
-573
-70
-287
-63
Financing Cash Flow
33
-117
2
286
-89
436
-140
-60
-110
Change in Cash
-34
27
23
6
12
-12
63
-143
155

Global Institutional Holdings in Collegium Pharmaceutical Inc.

Funds
Holdings
State Street Corp
4.39%
Dimensional Fund Advisors, Inc.
2.57%
Geode Capital Management, LLC
2.53%
Principal Financial Group Inc
3.99%
HHG PLC
5.63%

Insights on Collegium Pharmaceutical Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 193.52M → 199.87M (in $), with an average increase of 3.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 116.5% return, outperforming this stock by 96.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation Common Stock has given 59.6% return, outperforming this stock by 84.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 31.50M → -15.05M (in $), with an average decrease of 88.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, COLL stock has moved down by -22.2%

About Collegium Pharmaceutical Inc.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
OrganisationCollegium Pharmaceutical Inc.
Headquarters100 Technology Center Drive, Stoughton, MA, United States, 02072
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Vikram Karnani
E-voting on sharesClick here to vote

Key Management of Collegium Pharmaceutical Inc.

Name

Title

Mr. David Dieter

Executive VP, General Counsel & Corporate Secretary

Mr. Ian Karp M.B.A.

Head of Investor Relations

Ms. Jessica Cotrone

Senior Vice President of Communications & Corporate Affairs

Ms. Jane Gonnerman

Executive Vice President of Strategy & Corporate Development

Mr. Scott Sudduth

EVP & Head of Technical Operations

Mr. Vikram Karnani

CEO, President & Director

Ms. Colleen Tupper

Executive VP & CFO

Dr. Thomas B. Smith FAAFP, M.D.

Executive VP & Chief Medical Officer

Mr. Dean J. Patras

Chief People Officer

FAQs

What is Collegium Pharmaceutical Inc. share price today?

Collegium Pharmaceutical Inc. share price today is $28.23 as on at the close of the market. Collegium Pharmaceutical Inc. share today touched a day high of $28.52 and a low of $27.14.

What is the 52 week high and 52 week low for Collegium Pharmaceutical Inc. share?

Collegium Pharmaceutical Inc. share touched a 52 week high of $50.79 on and a 52 week low of $25.47 on . Collegium Pharmaceutical Inc. stock price today i.e. is closed at $28.23,which is 44.41% down from its 52 week high and 10.84% up from its 52 week low.

What is Collegium Pharmaceutical Inc.'s market capitalisation today?

Collegium Pharmaceutical Inc. market capitalisation is $0.00T as on .

How to invest in Collegium Pharmaceutical Inc. Stock (COLL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Collegium Pharmaceutical Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Collegium Pharmaceutical Inc. Shares that will get you 0.0531 shares as per Collegium Pharmaceutical Inc. share price of $28.23 per share as on August 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy Collegium Pharmaceutical Inc. Stock (COLL) from India?

Indian investors can start investing in Collegium Pharmaceutical Inc. (COLL) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Collegium Pharmaceutical Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Collegium Pharmaceutical Inc. share’s latest price of $28.23 as on August 15, 2026 at 8:46 am IST, you will get 0.3542 shares of Collegium Pharmaceutical Inc.. Learn more about fractional shares .

What are the returns that Collegium Pharmaceutical Inc. has given to Indian investors in the last 5 years?

Collegium Pharmaceutical Inc. stock has given 58.59% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?